ArticleCureus2025
Familial Mediterranean Fever Intertwined With a Diagnosis of Crohn's Disease: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoinflammatory diseases are a group of disorders caused by the dysregulation of the innate immune system, leading to episodes of systemic inflammation, with familial Mediterranean fever (FMF) being the most common among them. Other inflammatory disorders have recently been associated with FMF, including inflammatory bowel disease, specifically Crohn's disease (CD). While the gastrointestinal involvement in FMF is not the most typical presentation, both FMF and CD can share clinical features that challenge their diagnosis and treatment. We present a case of a man in his 50s who initially presented with a fever and was subsequently diagnosed with FMF, followed by appropriate treatment. However, he received a later diagnosis of CD after experiencing therapeutic failure and the development of severe gastrointestinal symptoms. Significant clinical improvement occurred only after initiating targeted therapy for CD with infliximab. This case illustrates the complexity and the diagnostic and therapeutic challenges that arise when these two diseases coexist, emphasizing the importance of a multidisciplinary approach to achieve better clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.